Search

everythinglearnresearchcommunity

for

Search:↓

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Understanding hair growth pathways can lead to better hair loss treatments.

Caffeine may help with hair loss, but more research is needed.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

Skin, hair, and nail changes can help detect eating disorders early.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Understanding hair health and disorders is important for effective treatment.

Spironolactone can effectively treat hair loss with manageable side effects.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

Consider Sertoli-Leydig cell tumors in Peutz-Jeghers syndrome patients with adnexal masses.

PCOS management involves lifestyle changes, hormonal treatments, and medications to address symptoms and improve insulin sensitivity.

Postmenopausal women with unusual hair growth should be checked for ovarian tumors.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Delayed puberty often runs in families, can affect growth, and may need hormone treatment.

Hair disorders include hair loss, excessive hair growth, and ingrown hairs, with various treatments available depending on the cause.